The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

✍ Scribed by J.S. Sidhu; D. Cowan; J.C. Kaski

• Book ID: 113413874
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 35 KB
• Volume: 13
• Category: Article
• ISSN: 1062-1458
• DOI: 10.1016/j.accreview.2003.12.026